News

Clínic Barcelona

Research November 10 2022

Hospital Clínic-IDIBAPS and the CIBER have signed an agreement with Eiken Chemical to assess the efficacy of a new fecal test for screening for colorectal cancer

The Japanese company, leader in screening for colorectal cancer worldwide, will fund the first phase of a multicenter clinical trial led by Antoni Ca1

Clínic Barcelona

Research October 14 2022

Launch of the European project ColoMARK, in which IDIBAPS is a partner

Meritxell Gironella will lead the Institute's contribution to the project, which is financed by Horizon Europe funding from the European Union’s Mari1

Clínic Barcelona

Research September 23 2022

IDIBAPS is a partner in the OperA project, financed by the Horizon Europe programme

Maria Pellisé will lead the Institute's contribution to the project, which is aimed at validating the use of artificial intelligence-assisted colonos1

Clínic Barcelona

Research July 11 2022

What research is being done in pancreatic cancer?

The main areas of research at the bench focus on finding biomarkers for early detection of the disease, on understanding the molecular mechanisms of1

Clínic Barcelona

Research November 11 2021

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organization1

3 3

page1
page2
page3 , current page.

News

Hospital Clínic-IDIBAPS and the CIBER have signed an agreement with Eiken Chemical to assess the efficacy of a new fecal test for screening for colorectal cancer

Launch of the European project ColoMARK, in which IDIBAPS is a partner

IDIBAPS is a partner in the OperA project, financed by the Horizon Europe programme

What research is being done in pancreatic cancer?

The AECC awards Hospital Clínic-IDIBAPS 2.1 million euros for cancer research

navigation between pages below